1 Long-term visual acuity between 20/20 and 20/40 |
2 |
108 |
Odds Ratio (M-H, Fixed, 95% CI) |
1.11 [0.47, 2.61] |
2 Short-term visual acuity from 20/20 to 20/40 |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
3 Final visual acuity between 20/20 and 20/40 |
2 |
143 |
Odds Ratio (M-H, Fixed, 95% CI) |
1.56 [0.53, 4.56] |
4 Time to resolution of primary hemorrhage (days) |
|
|
Other data |
No numeric data |
5 Risk of secondary hemorrhage |
6 |
330 |
Odds Ratio (M-H, Fixed, 95% CI) |
0.25 [0.11, 0.57] |
6 Time to rebleed (days) |
|
|
Other data |
No numeric data |
7 Risk of corneal blood stain |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
8 Risk of glaucoma or elevated intraocular pressure (IOP) |
2 |
83 |
Odds Ratio (M-H, Fixed, 95% CI) |
0.35 [0.06, 1.98] |
9 Risk of glaucoma or increases in IOP |
|
|
Other data |
No numeric data |
9.1 Transient increase in IOP |
|
|
Other data |
No numeric data |
9.2 Persistent increase in IOP |
|
|
Other data |
No numeric data |
10 Risk of optic atrophy |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
11 Adverse effects: nausea or vomiting |
3 |
131 |
Odds Ratio (M-H, Fixed, 95% CI) |
11.76 [2.59, 53.46] |
12 Duration of hospitalization (days) |
|
|
Other data |
No numeric data |